In addition, the reconstitution of NLRP3 inflammasome through the E2/ERβ/MAPK estrogen pathway seems to reverse the malignant phenotype of HCC, reinforcing its tumor-suppressive effect [64]. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.